N. Nandhagopal

Neuregulin-1 Administration Protocols Sufficient for Stimulating Cardiac Regeneration in Young Mice Do Not Induce Somatic, Organ, or Neoplastic Growth

B. Polizzotti, B. Ganapathy, D. Bennett, 2016, PloS one.

Abstract 17: Preclinical and phase 1 trial results of JI-101, a novel, oral tyrosine kinase inhibitor that selectively targets VEGFR2, EphB4, and PDGFRβ

D. Brittelli, L. Miller, M. Velleca, 2010 .